Emerald Advisers, LLC Catalyst Pharmaceuticals, Inc. Transaction History

Emerald Advisers, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 29, 2020	SELL	$3.67 - $5.7 $4.32 Million - $6.7 Million	-1,175,958 Closed	0 $0
Q3 2019 Oct 31, 2019	BUY	$3.89 - $7.43 $4.57 Million - $8.74 Million	1,175,958 New	1,175,958 $6.24 Million
Q2 2018 Jul 31, 2018	SELL	$2.26 - $3.84 $3.04 Million - $5.17 Million	-1,346,316 Closed	0 $0
Q1 2018 Apr 26, 2018	SELL	$2.39 - $4.01 $61,136 - $102,575	-25,580 Reduced 1.86%	1,346,316 $3.22 Million
Q4 2017 Feb 05, 2018	BUY	$2.51 - $4.4 $3.44 Million - $6.04 Million	1,371,896	1,371,896 $5.36 Million

348

98.5M

13.4K

11.7K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.55B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Emerald Advisers, LLC with notifications on news.